CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-01 | Subramanian Sanjay Chief Financial Officer | Grant or award · Option (Right to Buy) | +800,000 | 800,000 | ||
| 2021-01-01 | Kumar Ramesh Director | Grant or award · Option (Right to Buy) | +126,000 | 126,000 | ||
| 2021-01-01 | Fernandes Prabhavathi Director | Grant or award · Option (Right to Buy) | +126,000 | 126,000 | ||
| 2021-01-01 | Potti Manish Director | Grant or award · Option (Right to Buy) | +126,000 | 126,000 | ||
| 2021-01-01 | Castillo Kirsten Director | Grant or award · Option (Right to Buy) | +126,000 | 126,000 | ||
| 2021-01-01 | Zhang Junge Director | Grant or award · Option (Right to Buy) | +126,000 | 126,000 | ||
| 2020-08-14 | Tammara Vijay Senior Vice President | Grant or award · Options (Right to Buy) | +50,000 | 50,000 | ||
| 2020-05-28 | Castillo Kirsten Director | Purchase | +75,000 | $0.31 | $23K | 75,000 |
| 2020-05-07 | Musunuri Shankar Chief Executive Officer | Grant or award · Options (Right to Buy) | +1,357,145 | 1,357,145 | ||
| 2020-05-05 | Subramanian Sanjay Chief Financial Officer | Grant or award · Options (Right to Buy) | +369,256 | 369,256 | ||
| 2020-05-05 | Arumugham Rasappa Chief Scientific Officer | Grant or award · Options (Right to Buy) | +144,766 | 144,766 | ||
| 2020-05-05 | JORGENSEN DANIEL Chief Medical Officer | Grant or award · Options (Right to Buy) | +109,913 | 109,913 | ||
| 2020-05-05 | Beck Kelly Vice President | Grant or award · Options (Right to Buy) | +31,916 | 31,916 | ||
| 2020-05-05 | Tammara Vijay Senior Vice President | Grant or award · Options (Right to Buy) | +20,573 | 20,573 | ||
| 2020-04-05 | Castillo Kirsten Director | Grant or award · Option (Right to Buy) | +54,000 | 54,000 | ||
| 2020-04-05 | Fernandes Prabhavathi Director | Grant or award · Option (Right to Buy) | +54,000 | 54,000 | ||
| 2020-01-02 | Beck Kelly Vice President | Grant or award · Options (Right to Buy) | +86,596 | 86,596 | ||
| 2020-01-02 | Musunuri Shankar Chief Executive Officer | Grant or award · Options (Right to Buy) | +933,528 | 933,528 | ||
| 2020-01-02 | JORGENSEN DANIEL Chief Medical Officer | Grant or award · Options (Right to Buy) | +101,470 | 101,470 | ||
| 2020-01-02 | Arumugham Rasappa Chief Scientific Officer | Grant or award · Options (Right to Buy) | +111,372 | 111,372 |
Page 14 of 27 · 525 trades